Effect of Recombinant or Lymphoblastoid Interferon-α on Alanine Aminotransferase in Patients with Chronic Hepatitis C or Chronic Non-A Non-B Hepatitis F. BardelliA. MessoriN. Martini Clinical Use 25 October 2012 Pages: 239 - 254
Effects of Amlodipine on Platelet Aggregation in Hypertensive Patients C. RostagnoA. ColellaG. F. Gensini Clinical Pharmacodynamics 25 October 2012 Pages: 255 - 259
A Limited Sampling Model with Bayesian Estimation to Determine Inulin Pharmacokinetics Using the Population Data Modelling Program P-PHARM Jean-Marie KinowskiFrançoise BressolleRoberto Gomeni Clinical Pharmacokinetics 25 October 2012 Pages: 260 - 269
Effect of Food on the Pharmacokinetics of Meloxicam after Oral Administration D. TürckU. BuschG. Nehmiz Pharmacokinetics 25 October 2012 Pages: 270 - 276
A Randomised Study Comparing Digoxin and Propafenone in the Treatment of Recent Onset Atrial Fibrillation Raffaele BaroffioGuido TisiPierluigi Annoni Clinical Use 25 October 2012 Pages: 277 - 283
Preliminary Trial of the Efficacy of Bucillamine in Korean Patients with Rheumatoid Arthritis Seong Yoon KimIn H. LeeDae H. Yoo Clinical Use 25 October 2012 Pages: 284 - 290
Placebo-Controlled Evaluation of the Efficacy and Tolerability of Permixon® in Benign Prostatic Hyperplasia after Exclusion of Placebo Responders JL DescotesJJ RambeaudG Faure Clinical Use 25 October 2012 Pages: 291 - 297
Electrophysiological Effects of Mexiletine on Atrial Vulnerability in Patients with Paroxysmal Atrial Fibrillation Itsuki OmoriK. FurukawaM. Nakagawa Short Communication 25 October 2012 Pages: 298 - 302